Experimental models to identify antimetastatic drugs: are we there yet? A position paper

Ann N Y Acad Sci. 1999 Jun 30:878:208-11. doi: 10.1111/j.1749-6632.1999.tb07686.x.

Author

S Zucker¹

Affiliation

¹ Veterans Administration Medical Cancer, Northport, New York 11768, USA. zucker.stanley@northport.va.gov

PMID: 10415732
DOI: 10.1111/j.1749-6632.1999.tb07686.x

No abstract available

MeSH terms

Animals
Antineoplastic Agents / chemical synthesis*
Antineoplastic Agents / therapeutic use
Clinical Trials as Topic
Drug Design
Humans
Metalloendopeptidases / antagonists & inhibitors*
Neoplasm Metastasis / prevention & control*
Neoplasms, Experimental / drug therapy*
Neoplasms, Experimental / pathology
Protease Inhibitors / chemical synthesis*
Protease Inhibitors / therapeutic use*
Tissue Inhibitor of Metalloproteinases / therapeutic use*

Substances

Antineoplastic Agents
Protease Inhibitors
Tissue Inhibitor of Metalloproteinases
Metalloendopeptidases